SchwartzLM, WoloshinS, FowlerFJJr, WelchHG. Enthusiasm for cancer screening in the United States. JAMA, 2004; 291:71–78.
2.
WardE, HalpernM, SchragN, et al.Association of insurance with cancer care utilization and outcomes. CA Cancer J Clin, 2008; 58:9–31.
3.
AyanianJZ, KohlerBA, AbeT, EpsteinAM. The relation between health insurance coverage and clinical outcomes among women with breast cancer. N Engl J Med, 1993; 329:326–331.
4.
ByersTE, WolfHJ, BauerKR, et al.The impact of socioeconomic status on survival after cancer in the United States: Findings from the National Program of Cancer Registries Patterns of Care Study. Cancer, 2008; 113:582–591.
5.
RodriguezMA, WardLM, Perez-StableEJ. Breast and cervical cancer screening: Impact of health insurance status, ethnicity, and nativity of Latinas. Ann Fam Med, 2005; 3:235–241.
6.
BlusteinJ. Medicare coverage, supplemental insurance, and the use of mammography by older women. N Engl J Med, 1995; 332:1138–1143.
7.
BuschSH, BarryCL, VegsoSJ, SindelarJL, CullenMR. Effects of a cost-sharing exemption on use of preventive services at one large employer. Health Aff (Millwood), 2006; 25:1529–1536.
8.
GuyGPJr.The effects of cost sharing on access to care among childless adults. Health Serv Res, 2010; 45:1720–1739.
9.
LiangSY, PhillipsKA, TyeS, HaasJS, SakowskiJ. Does patient cost sharing matter? Its impact on recommended versus controversial cancer screening services. Am J Manag Care, 2004; 10:99–107.
10.
RezayatmandR, PavlovaM, GrootW. The impact of out-of-pocket payments on prevention and health-related lifestyle: A systematic literature review. Eur J Public Health, 2013; 23:74–79.
11.
SolankiG, SchaufflerHH. Cost-sharing and the utilization of clinical preventive services. Am J Prev Med, 1999; 17:127–133.
12.
SolankiG, SchaufflerHH, MillerLS. The direct and indirect effects of cost-sharing on the use of preventive services. Health Serv Res, 2000; 34:1331–1350.
13.
TrivediAN, RakowskiW, AyanianJZ. Effect of cost sharing on screening mammography in Medicare health plans. N Engl J Med, 2008; 358:375–383.
14.
WharamJF, GravesAJ, LandonBE, ZhangF, SoumeraiSB, Ross-DegnanD. Two-year trends in colorectal cancer screening after switch to a high-deductible health plan. Med Care, 2011; 49:865–871.
15.
CDC.gov.. Breast Cancer Screening Guidelines for Women 2016; Breast Cancer Screening Guidelines for Women, 2018. Available at: https://www.cdc.gov/cancer/breast/pdf/BreastCancerScreeningGuidelines.pdf Accessed August31, 2018, 2018.
16.
SabatinoSA, ThompsonTD, MillerJW, BreenN, WhiteMC, BreslauE, ShoemakerML. Prevalence of out-of-pocket payments for mammography screening among recently screened women. J Womens Health,, 2019; 28:910–918.
17.
MehtaSJ, PolskyD, ZhuJ, et al.ACA-mandated elimination of cost sharing for preventive screening has had limited early impact. Am J Managed Care, 2015; 21:511–517.
18.
TrivediAN, LeyvaB, LeeY, PanagiotouOA, DahabrehIJ. Elimination of cost sharing for screening mammography in Medicare advantage plans. N Engl J Med, 2018; 378:262–269.
19.
KahnemanD, TverskyA. Prospect theory: An analysis of decision under risk. Econometrica, 1979; 47:263–292.
20.
PurnellJQ, ThompsonT, KreuterMW, McBrideTD. Behavioral economics: “nudging” underserved populations to be screened for cancer. Prev Chronic Dis, 2015; 12:E06.
21.
BarnesAJ, GroskaufmanisL, Thomson NBIII. Promising approaches from behavioral economics to improve patient lung cancer screening decisions. J Am Coll Radiol, 2016; 13:1566–1570.
22.
MehtaSJ, AschDA. How to help gastroenterology patients help themselves: Leveraging insights from behavioral economics. Clin Gastroenterol Hepatol, 2014; 12:711–714.
23.
MehtaSJ, KhanT, GuerraC, et al.A randomized controlled trial of opt-in versus opt-out colorectal cancer screening outreach. Am J Gastroenterol, 2018 [Epub ahead of print].
24.
SamuelsonW, ZeckhauserR. Status quo bias in decision making. J Risk Uncertainty, 1988; 1:7–59.
25.
RutterDR. Attendance and reattendance for breast cancer screening: A prospective 3-year test of the theory of planned behaviour. Br J Health Psychol, 2000; 5:1–13.
26.
LechnerL, de VriesH, OffermansN. Participation in a breast cancer screening program: Influence of past behavior and determinants on future screening participation. Prev Med, 1997; 26:473–482.
27.
ChapmanGB, ElsteinAS. Valuing the future: Temporal discounting of health and money. Med Decis Making, 1995; 15:373–386.
28.
WeinsteinN. Unrealistic optimism about future life events. J Pers Soc Psychol, 1980; 39:806–820.
29.
AllgoodPC, MaroniR, HudsonS, et al.Effect of second timed appointments for non-attenders of breast cancer screening in England: A randomised controlled trial. Lancet Oncol, 2017; 18:972–980.
30.
HudsonS, BrazilD, TehW, DuffySW, MylesJP. Effectiveness of timed and non-timed second appointments in improving uptake in breast cancer screening. J Med Screen, 2016; 23:160–163.
31.
USPTF. The Community Guide, What works to promote health. Cancer prevention and control: Client-oriented interventions to increase breast, cervical, and colorectal cancer screening. 2016. Available at: www.thecommunityguide.org/cancer/screening/client-oriented/index.html Accessed September9, 2016.
